Schedule 13G ownership disclosure

INOVIO PHARMACEUTICALS INC

COMMON STOCK · CUSIP: 45773H409

Event date: 2025-11-28

Reporting persons may disclose overlapping interests. Their amounts are shown individually and are not added into a filing total.

Filing-level shares
Unavailable
Percent of class
Unavailable
  • FMR LLC

    Shares: 9,846,664.00 · Class: 14.8%

  • Abigail P. Johnson

    Shares: 9,846,664.00 · Class: 14.8%

Amounts are as disclosed in this filing. Schedule type alone does not establish investment intent.

Source: SEC EDGAR filing

Filing metadata

Accession number
0000315066-25-002964
Form type
SCHEDULE 13G
Filer
FMR LLC
CIK
CIK 315066
Filed
Dec 05, 2025
Reporting period
Nov 28, 2025
Description
Schedule 13G beneficial ownership

Explore SEC Filings Hub